Condition: Breast Implant Revision · Breast Augmentation Complications · Primary Breast Augmentation Surgery · Sponsor: BellaSeno Pty Ltd
The objective of the clinical investigation is to demonstrate safety and clinical performance of the absorbable polycaprolactone (PCL) breast scaffold combined with autologous fat grafting (AFG) for primary breast augmentation and breast augmentation revision surgery following previous breast implant insertion. The material (PCL) has been in clinical use for many decades and is absorbable. This study follows the successful completion of a 2-year evaluation of the safety and feasibility of this technique performed by the Royal Brisbane and Women's Hospital (ClinicalTrials.gov ID: NCT05437757). The main question it aims to answer is: "Is PCL Breast Scaffold with autologous fat graft a safe and effective method for soft tissue reconstruction following breast implant revision and for primary breast augmentation?". Participants will: * Undergo removal of their existing silicone breast implant (only for participants undergoing breast implant revision, if the implant has not been previously removed), * Receive implantation of a PCL Breast Scaffold combined with autologous fat grafting (AFG), and * Attend follow-up visits at 1 week, 3 months, 6 months, and annually for up to 5 years for clinical assessments and questionnaires.
This description comes directly from the study's public registry record.
Professor Owen Ung · +61 736460177 · owen.ung@health.qld.gov.au
Professor Anand Deva · +61(2) 95252340 · anand.deva@ishc.org.au
Always discuss trial participation with your own doctor first.
| Macquarie University Hospital | Sydney, New South Wales, Australia | Recruiting |
| Westmead Hospital, Lakeview Private Hospital | Sydney, New South Wales, Australia | Not Yet Recruiting |
| Royal Brisbane and Women's Hospital (RBWH), Herston Biofabrication Institute (HBI) | Brisbane, Queensland, Australia | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07367698